Article

PreferCo and Glatt have opened a precision fermentation scale-up centre in Hyderabad, shortly after India's free trade agreement with the EU. This facility aims to bridge lab research and commercial manufacturing, enhancing India's BioE3 strategy for biomanufacturing.

It supports 1,500-litre bioreactors and integrates advanced automation and AI. The centre will extend applications beyond biopharmaceuticals into functional foods and sustainable materials. India's bioeconomy, projected to grow from $10B in 2014 to $300B by 2030, will benefit from this infrastructure, which aims to streamline the path from proof-of-concept to commercial production.